AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,260,885 | +34.7% | 18,041 | +38.5% | 0.16% | +40.0% |
Q2 2023 | $936,120 | -61.9% | 13,027 | -64.3% | 0.12% | -46.5% |
Q2 2021 | $2,460,000 | +8.4% | 36,467 | -9.0% | 0.22% | +1.9% |
Q1 2021 | $2,270,000 | -31.8% | 40,093 | -1.9% | 0.21% | -28.0% |
Q4 2020 | $3,329,000 | -7.2% | 40,872 | -18.8% | 0.29% | +5.0% |
Q3 2020 | $3,588,000 | +19.6% | 50,358 | +38.1% | 0.28% | +10.7% |
Q2 2020 | $3,001,000 | +28.7% | 36,466 | -8.0% | 0.25% | +5.4% |
Q1 2020 | $2,332,000 | – | 39,629 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |